About this trial
The purpose of this study is to explore the feasibility and acceptability of a nurse-led, coping, and supportive care intervention for patients with triple-negative breast cancer. The intervention aims to improve psychosocial outcomes in patients with triple-negative breast cancer (e.g., quality of life (QOL), anxiety, fear of cancer recurrence (FCR)).
Eligibility criteria
Qualifiers
Diagnosis of stage 1-3 triple-negative breast cancer
Age ≥ to 18 years
Between one and 12 months post curative therapy
Reporting distress at least 4/10 on a one-item screener
Disqualifiers
Patients with stage 4 cancer
Patients with impaired cognition or serious mental illness that would preclude participation in study procedures
Trial design
Treatments tested in this trial
- RESTORE
- Enhanced Usual Care
Treatment groups
Sponsors and collaborators
Massachusetts General Hospital
Lead sponsor
National Cancer Institute (NCI)
Collaborator